Company Data
Eagle Pharmaceuticals Inc.
Ticker
EGRX
Current Price
$2.9 7.41%
Market Cap
$37.7M
Price Target
Refer to Report
Volume
7.8K
52wk Range
$0.0025 - $6.37
Overview
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, docetaxel injection, non-alcohol formulation and Bendeka. The company currently have multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.